299 related articles for article (PubMed ID: 9176068)
1. Tumour necrosis factor and Crohn's disease.
Van Deventer SJ
Gut; 1997 Apr; 40(4):443-8. PubMed ID: 9176068
[No Abstract] [Full Text] [Related]
2. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
Bell S; Kamm MA
Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
[No Abstract] [Full Text] [Related]
3. Tumour-necrosis-factor antibody treatment in Crohn's disease.
Derkx B; Taminiau J; Radema S; Stronkhorst A; Wortel C; Tytgat G; van Deventer S
Lancet; 1993 Jul; 342(8864):173-4. PubMed ID: 8101267
[No Abstract] [Full Text] [Related]
4. Why do anti-tumor necrosis factor antibodies work in Crohn's disease?
Sands BE
Rev Gastroenterol Disord; 2004; 4 Suppl 3():S10-7. PubMed ID: 15580148
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?
Hollander D
Am J Gastroenterol; 2002 Aug; 97(8):1867-8. PubMed ID: 12190145
[No Abstract] [Full Text] [Related]
6. Anti-TNF antibody treatment of Crohn's disease.
van Deventer SJ
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
[No Abstract] [Full Text] [Related]
7. Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance.
Danese S; Pagano N; Angelucci E; Stefanelli T; Repici A; Omodei P; Daperno M; Malesci A
Curr Med Chem; 2007; 14(14):1489-97. PubMed ID: 17584058
[TBL] [Abstract][Full Text] [Related]
8. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
Hawkey CJ; Stack WA
N Engl J Med; 1998 Jan; 338(5):333-4. PubMed ID: 9446034
[No Abstract] [Full Text] [Related]
9. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
[TBL] [Abstract][Full Text] [Related]
10. Antibody to tumor necrosis factor in the treatment of Crohn's disease.
Stricker T; Braegger CP
J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):369-70. PubMed ID: 9740217
[No Abstract] [Full Text] [Related]
11. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Targan SR; Hanauer SB; van Deventer SJ; Mayer L; Present DH; Braakman T; DeWoody KL; Schaible TF; Rutgeerts PJ
N Engl J Med; 1997 Oct; 337(15):1029-35. PubMed ID: 9321530
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and mucosal inflammatory response in Crohn's disease.
van Deventer SJ
Eur J Surg; 1998 Dec; 164(12):897-901. PubMed ID: 10029384
[No Abstract] [Full Text] [Related]
13. Strategies targeting tumor necrosis factor in Crohn's disease.
Sandborn WJ
Acta Gastroenterol Belg; 2001; 64(2):170-2. PubMed ID: 11475128
[TBL] [Abstract][Full Text] [Related]
14. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
Bauditz J; Lochs H; Schreiber S
N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
[No Abstract] [Full Text] [Related]
15. CD4 antibody treatment in Crohn's disease.
Stronkhorst A; Tytgat GN; van Deventer SJ
Scand J Gastroenterol Suppl; 1992; 194():61-5. PubMed ID: 1298050
[TBL] [Abstract][Full Text] [Related]
16. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Kenney JS; Baumann R; Poindron P; Duclos B
Gut; 1996 Nov; 39(5):684-9. PubMed ID: 9026483
[TBL] [Abstract][Full Text] [Related]
17. CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.
Stronkhorst A; Radema S; Yong SL; Bijl H; ten Berge IJ; Tytgat GN; van Deventer SJ
Gut; 1997 Mar; 40(3):320-7. PubMed ID: 9135519
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Crohn's disease with anti-TNF alpha].
Lémann M
Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
[No Abstract] [Full Text] [Related]
19. Monoclonal antibody approved for treatment of Crohn's disease.
Freeman TR; Piascik P
J Am Pharm Assoc (Wash); 1998; 38(6):770-2. PubMed ID: 9861797
[No Abstract] [Full Text] [Related]
20. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
Brown SJ; Abreu MT
Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
